Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Second Affiliated Hospital, School of Medicine, Zhejiang University | OTHER |
| Shanghai Zhongshan Hospital | OTHER |
| Henan Provincial People's Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The aims of this study are to 1. Assess the preoperative and postoperative atrial and ventricular structure and function comprehensively in heart transplantation; 2. Explore the early, accurately and non-invasively indicators for evaluating myocardial fibrosis in end-stage heart failure, as well detecting acute rejection (AR),coronary allograft vasculopathy(CAV) and adverse clinical events in heart transplant patients by using conventional and the advanced echocardiography.
This study will enrolled 1000 HT patients and 500 healthy controls, and the cardiac structure and function will be evaluated by ultrasound multimodal imaging. And the study aimed to 1. Assess the preoperative and postoperative atrial and ventricular structure and function comprehensively in heart transplantation; 2. Explore the early, accurately and non-invasively indicators for evaluating myocardial fibrosis in end-stage heart failure, as well detecting acute rejection(AR),coronary allograft vasculopathy(CAV) and adverse clinical events in heart transplant patients by using conventional and the advanced echocardiography.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HT group | Patients have echocardiography examination before and after heart transplantation. | ||
| Control group | healthy volunteers who had no history of hypertension, diabetes mellitus, renal failure or other organic diseases based on physical examinations, biochemical tests, electrocardiogram, echocardiography were enrolled as control group |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Using Image-Pro Plus 6.0 software to measure myocardial fibrosis | The extent of myocardial fibrosis of the myocardial tissue from the removed heart during heart transplant was measured by Image-Pro Plus 6.0 software up to 1 year after heart transplant | the measurement of myocardial fibrosis up to 1 year after heart transplant |
| All cause death after the inclusion of the study | All cause death after HT was obtained via telephone interview with family members; contact with his/her physicians; or hospital records every year | All cause death happened after inclusion of this study, up to 5 years |
| Acute rejection after the inclusion of the study | Acute rejection after the inclusion of the study was obtained at regular intervals via telephone interview with the patient, or if deceased, with family members; contact with his/her physicians; or hospital records every year | Acute rejection happened after inclusion of this study, up to 5 years |
| Cardiac allograft vasculopathy after the inclusion of the study | Cardiac allograft vasculopathy after the inclusion of the study was obtained at regular intervals via telephone interview with the patient, or if deceased, with family members; contact with his/her physicians; or hospital records every year | Cardiac allograft vasculopathy happened after inclusion of this study, up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Major adverse cardiac events after the inclusion of the study | Major adverse cardiac events after the inclusion of the study was obtained at regular intervals via telephone interview with the patient, or if deceased, with family members; contact with his/her physicians; or hospital records every year | Major adverse cardiac events happened after inclusion of this study，up to 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
ALL adult HT recipients were consecutive prospectively enrolled who underwent transthoracic echocardiography (TTE) for surveillance at their routine follow-up visits at our institution
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Li Zhang, PhD | Contact | 18907131488 | zli429@hust.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Li Zhang, PhD | Department of Ultrasound, Union Hospital, Wuhan, China | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Wuhan Asia Heart Hospital |
| OTHER |
| Guangdong Provincial People's Hospital | OTHER |
Not provided
Not provided
Not provided